Glucocorticoid exposure causes disrupted glucoregulation, cardiac inflammation and elevated dipeptidyl peptidase-4 activity independent of glycogen synthase kinase-3 in female rats

References

• Aroor, A.R., Mandavia, C.H., and Sowers, J.R., 2012. Insulin resistance and heart failure: molecular mechanisms. Heart failure clinics, 8, 609–617.
   PubMed Web of Science ®Google Scholar
• Aroor, A.R., et al., 2017. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF 31P2 expression, inflammation and fibrosis in female mice. Cardiovascular diabetology, 16, 16.
   PubMed Web of Science ®Google Scholar
• Ashrafian, H., Frenneaux, M.P., and Opie, L.H., 2007. Metabolic mechanisms in heart failure. Circulation, 116, 434–438.
   PubMed Web of Science ®Google Scholar
• Banerjee, D., et al., 2013. Insulin resistance and risk of incident heart failure; cardiovascular health study. Circulation heart failure, 6, 364–370.
   PubMed Web of Science ®Google Scholar
• Beckman, J.A., Creager, M.A., and Libby, P., 2002. Diabetes and atherosclerosis epidemiology, pathophysiology, and management. Journal of the American medical association, 287 (19), 2570–2581.
   PubMed Web of Science ®Google Scholar
• Boudina, S. and Dale, A.E., 2007. Diabetic cardiomyopathy revisited. Circulation, 115, 3213–3223.
   PubMed Web of Science ®Google Scholar
• Cai, L. and Kang, Y.J., 2001. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovascular Toxicology, 1, 181–193.
   PubMedGoogle Scholar
• Chaudhary, K., et al., 2013. Uric acid – key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal medicine, 3, 208–220.
   PubMed Web of Science ®Google Scholar
• Cook-Mills, J.M., Marchese, M.E., and Abdala-Valencia, H., 2011. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxidants & redox signaling, 15 (6), 1607–1638.
   PubMed Web of Science ®Google Scholar
• Cybulsky, M.I., et al., 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. Journal of clinical investigation, 107, 1255–1262.
   PubMed Web of Science ®Google Scholar
• de Vries, W.B., et al., 2002. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatric research, 52, 900–906.
   PubMed Web of Science ®Google Scholar
• Dolatabadi, A.A. and Mahboubi, M., 2015. A study of the influence of dexamethasone on lipid profile and enzyme lactate dehydrogenase. Journal of medicine and life, 8 (3), 72–76.
   Google Scholar
• dos Santos, L., et al., 2013. Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure. Circulation heart failure, 6, 1029–1038.
   PubMed Web of Science ®Google Scholar
• Drucker, D.J. and Nauck, M.A., 2006. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368, 1696–1705.
   PubMed Web of Science ®Google Scholar
• Eckart, R.E., et al., 2004. Sudden death in young adults: a 25-year review of autopsies in military recruits. Annals of internal medicine, 141 (11), 829–834.
   PubMed Web of Science ®Google Scholar
• Frangogiannis, N.G., 2012. Regulation of the inflammatory response in cardiac repair. Circulation research, 110, 159–173.
   PubMed Web of Science ®Google Scholar
• Gersch, C., et al., 2008. Inactivation of nitric oxide by uric acid. Nucleosides, nucleotides & nucleic acids, 27, 967–978.
   PubMed Web of Science ®Google Scholar
• Gomes, P.R., et al., 2014. Long-term disruption of maternal glucose homeostasis induced by prenatal glucocorticoid treatment correlates with miR-29 upregulation. American journal of physiology endocrinology and metabolism, 306, E109–E120.
   PubMed Web of Science ®Google Scholar
• Guo, B., et al., 2016. GSK-3β mediates dexamethasone-induced pancreatic β cell apoptosis. Life sciences, 144, 1–7.
   PubMed Web of Science ®Google Scholar
• Gupta, R., et al., 2008. Epidemiology and causation of coronary heart disease and stroke in India. Heart (British cardiac society), 94, 16–26.
   PubMed Web of Science ®Google Scholar
• Hadoke, P.W.F., Iqbal, J., and Walker, B.R., 2009. Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British journal of pharmacology, 156, 689–712.
   PubMed Web of Science ®Google Scholar
• Holness, M.J. and Sugden, M.C., 2001. Dexamethasone during late gestation exacerbates peripheral insulin resistance and selectively targets glucose-sensitive functions in cell and liver. Endocrinology, 142 (9), 3742–3748.
   PubMed Web of Science ®Google Scholar
• Ikeda, J., et al., 2016. Cardiac DPP-4 inhibition by sexagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats. Journal of pharmacological sciences, 132, 65–70.
   PubMed Web of Science ®Google Scholar
• Jope, R.S., Yuskaitis, C.J., and Beurel, E., 2007. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochemical research, 32, 577–595.
   PubMed Web of Science ®Google Scholar
• Kramla, J., et al., 2003. Glucocorticoid agonistic and antagonistic effects of mifepristone and onapristone on thymocyte subset composition and CD26/dipeptidyl peptidase IV activity in infant male rats. Journal of steroid biochemistry & molecular biology, 87, 85–96.
   PubMed Web of Science ®Google Scholar
• La Mear, N.S., MacGilvray, S.S., and Myers, T.F., 1997. Dexamethasone-induced myocardial hypertrophy in neonatal rats. Biology of the neonate, 72, 175–180.
   PubMedGoogle Scholar
• Lamer, D., et al., 2011. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes, 60, 1917–1925.
   PubMed Web of Science ®Google Scholar
• Libby, P., Ridker, P.M., and Maseri, A., 2002. Inflammation and atherosclerosis. Circulation, 105, 1135–1143.
   PubMed Web of Science ®Google Scholar
• Libby, P., 2006. Inflammation and cardiovascular disease mechanisms. American journal of clinical nutrition, 83, 456S–460S.
   PubMed Web of Science ®Google Scholar
• Lim, H.Y., et al., 2007. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology, 122, 47–53.
   PubMed Web of Science ®Google Scholar
• Lister, K., et al., 2006. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovascular research, 70, 555–565.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2011. Glucocorticoids decrease body weight and food intake and inhibit appetite regulatory peptide expression in the hypothalamus of rats. Experimental and therapeutic medicine, 2 (5), 977–984.
   PubMed Web of Science ®Google Scholar
• Madonna, R., Massaro, M., and De-Caterina, R., 2008. Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells. Biochimica et Biophysica Acta, 1782, 511–516.
   PubMed Web of Science ®Google Scholar
• Madonnaa, R. and De Caterina, R., 2012. Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia. Revista espanola de cardiologia, 65 (4), 309–313.
   PubMed Web of Science ®Google Scholar
• Mamas, M.A., et al., 2010. Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? Journal of cardiac failure, 16, 761–768.
   PubMed Web of Science ®Google Scholar
• Marchant, D.J., et al., 2012. Inflammation in myocardial diseases. Circulation research, 110, 126–144.
   PubMed Web of Science ®Google Scholar
• Maulik, S.K. and Kumar, S., 2012. Oxidative stress and cardiac hypertrophy: a review. Toxicology mechanisms and methods, 2, 359–366.
   Google Scholar
• Mitsuya, N., et al., 2004. Efficacy of steroid therapy for pacing failure in a patient with chronic myocarditis. Internal medicine, 43, 213–217.
   PubMed Web of Science ®Google Scholar
• Muniyappa, R. and Sowers, J.R., 2013. Role of insulin resistance in endothelial dysfunction. Reviews in endocrine metabolic disorders, 14, 5–12.
   PubMed Web of Science ®Google Scholar
• Ngkelo, A., Hoffmann, R.F., and Durham, A.L., 2015. Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD. American journal of physiology-lung cellular and molecular physiology, 309 (10), L1112–L1123.
   PubMed Web of Science ®Google Scholar
• Nikoulina, S.E., Ciaraldi, T.P., and Mudaliar, S., 2000. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes, 49, 263–271.
   PubMed Web of Science ®Google Scholar
• Olatunji, L.A., et al., 2017. Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats. Environmental toxicology and pharmacology, 52, 54–61.
   PubMed Web of Science ®Google Scholar
• Ong, S.L., et al., 2007. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clinical and experimental pharmacology and physiology, 34 (5-6), 517–519.
   PubMed Web of Science ®Google Scholar
• Pasupathi, P., et al., 2009. Biochemical cardiac markers in clinical cardiology. Journal of medicine, 10, 100–108.
   Google Scholar
• Petersons, C.J., et al., 2013. Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease. Diabetes care, 36, 2822–2829.
   PubMed Web of Science ®Google Scholar
• Protzek, A.O., et al., 2016. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin degrading enzyme. Journal of steroid biochemistry & molecular biology, 155, 1–8.
   PubMed Web of Science ®Google Scholar
• Rafacho, A., et al., 2014. Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes. Journal of endocrinology, 223, R49–R62.
   PubMed Web of Science ®Google Scholar
• Rajeshwari, T., et al., 2014. Valproic acid attenuate blood pressure, vascular remodeling and modulates ET-1 expression in L-NAME induced hypertensive rats. Journal of biomedicine and preventive nutrition, 4, 195–202.
   Google Scholar
• Ren, R., et al., 2012. Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology, 153 (11), 5346–5360.
   PubMed Web of Science ®Google Scholar
• Röhrborn, D., Wronkowitz, N., and Eckel, J., 2015. DPP4 in Diabetes. Frontiers in immunology, 6, 386
   PubMed Web of Science ®Google Scholar
• Ruparelia, N., et al., 2017. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nature reviews cardiology, 14, 133–144.
   PubMed Web of Science ®Google Scholar
• Ruzzin, J., Wagman, A.S., and Jensen, J., 2005. Glucocorticoid-induced insulin resistance in skeletal muscle: defects in insulin signaling and effects of selective glycogen synthase kinase-3 inhibitor. Diabetologia, 48 (10), 2119–2230.
   PubMed Web of Science ®Google Scholar
• Schäfer, S.C., et al., 2005. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. American journal of physiology heart and circulation physiology, 288, H436–H444.
   PubMed Web of Science ®Google Scholar
• Sorrell, M.J., et al., 2003. Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts. Archive of dermatology research and practice, 295, 160–168.
   PubMed Web of Science ®Google Scholar
• Spokoini, R., et al., 2010. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Molecular endocrinology, 24 (6), 1136–1150.
   PubMedGoogle Scholar
• Tanaseanu, C.M., et al., 2015. Lactate dehydrogenase a possible marker of progressive microvasculopathy and interstitial lung disease in systemic sclerosis. Acta Medica Mediterranea, 31, 941.
   Web of Science ®Google Scholar
• Targher, G., et al., 2001. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes care, 24, 1961–1966.
   PubMed Web of Science ®Google Scholar
• Van Der Velden, V.H., et al., 1999. Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics—comparison with healthy non- smokers and smokers and effects of inhaled glucocorticoids. Clinical and experimental allergy, 29, 813–823.
   PubMed Web of Science ®Google Scholar
• Van Genugten, R.E., et al., 2014. Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with metabolic syndrome? A randomized control trial. European journal of endocrinology, 170, 429–439.
   PubMed Web of Science ®Google Scholar
• Vaughan, O.R., et al., 2015. Corticosterone alters materno-fetal glucose partitioning and insulin signaling in pregnant mice. Journal of physiology, 593 (5), 1307–1321.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2006. Causes and characteristics of diabetic cardiomyopathy. Review of diabetic studies, 3, 108–117.
   PubMedGoogle Scholar
• Witteles, R.M. and Fowler, M.B., 2008. Insulin-resistant cardiomyopathy. Clinical evidence, mechanisms and treatment options. Journal of the American college of cardiology, 51, 93–102.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.N., et al., 2013. Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic-β cells. Molecular and cellular endocrinology, 375, 89–96.
   PubMed Web of Science ®Google Scholar
• Zheng, T., et al., 2014. Increased Plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the china national diabetes and metabolic disorders study. Journal of clinical endocrinology and metabolism, 99, E2330–E2334.
   PubMed Web of Science ®Google Scholar
• Zhi, L., et al., 2016. High uric acid induces insulin resistance in cardiomyocytes in vitro and in vivo. PLoS one, 11 (2), e0147737.
   PubMed Web of Science ®Google Scholar
• Zhong, J., Rao, X., and Rajagopalan, S., 2013. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardio-vascular disease. Atherosclerosis, 226, 305–314.
   PubMed Web of Science ®Google Scholar